Merriman Curhan Ford

Related by string. * MERRIMAN . Merrimans : linebackers Shawne Merriman . OLB Shawne Merriman . Merriman extracurricular activities . linebacker Shawne Merriman . San Diego Shawne Merriman / : Merriman Curhan . Annual Merriman Curhan . Curhan . Gary Curhan . brokerage Merriman Curhan / for . ford . FORD . FOR : Ford Motor Co. . Ford Motor Co . Ford Focus RS . ELSE FOR ANY DAMAGES * *

Related by context. All words. (Click for frequent words.) 67 Piper Jaffray 65 ThinkEquity 65 Thomas Weisel Partners 64 CE Unterberg Towbin 63 ThinkEquity Partners LLC 63 WR Hambrecht 62 Nasdaq MERR 61 ThinkEquity Partners 60 SG Cowen 60 Brean Murray Carret 60 Leerink Swann 60 ThinkEquity LLC 59 Wedbush 59 JMP Securities 59 Lazard Capital 58 Sidoti & 58 Pacific Growth Equities 58 JMP Securities LLC 58 Jefferies 57 Brion Tanous 57 Brean Murray 57 Inc. Nasdaq MERR 57 analyst Tim Savageaux 57 Stifel Nicolaus 57 Friedman Billings Ramsey 56 WR Hambrecht + 56 NASDAQ MERR 56 Thomas Weisel 56 Richard Fetyko 56 Kaufman Brothers 56 ANALYST TAKE Jefferies 55 Lazard Capital Markets 55 Craig Hallum 55 Feltl & 55 W. Baird 55 Stifel Nicholaus 55 CE Unterberg 54 Auriga USA 54 Craig Hallum Capital 54 Canaccord Adams 54 Merriman Curhan 54 analyst Colby Synesael 54 Brigantine Advisors 54 Canaccord Genuity 54 Ladenburg Thalmann 53 RW Baird 53 Ardour Capital 53 Wunderlich Securities 53 Kaufman Bros. 53 MDB Capital Group 53 analyst Richard Fetyko 53 Feltl 53 Piper Jaffrey 53 Inc. NASDAQ MERR 53 Janney Montgomery Scott 53 Wedbush Securities 53 FBR Capital Markets 52 Cochran Caronia 52 Northland Capital Markets 52 Piper Jaffray Cos. 52 ROTH Capital Partners 52 & Renshaw 52 CJS Securities 52 Broadpoint Capital 52 Adams Harkness 52 Unterberg Towbin 52 Sandler O'Neill 52 Ardour Capital Investments 52 CapStone Investments 51 analyst Liana Moussatos 51 Caris & 51 Piper Jaffray PJC 51 Leerink Swan 51 Kaufman Bros 51 Jefferies NYSE JEF 51 ROTH Capital 51 LifeTech Capital 51 Morgan Keegan 51 analyst Greg Mesniaeff 51 Satya Chillara 51 Chardan Capital Markets 51 Morgan Joseph TriArtisan 51 Kalpesh Kapadia 51 Wedbush Morgan 51 Punk Ziegel 51 Nollenberger Capital 51 Gerard Klauer Mattison 51 JMP Securities Research 51 ThinkPanmure 50 Eric Wold 50 Annual ICR XChange 50 Oppenheimer NYSE OPY 50 Sidoti Emerging 50 Prudential Equity 50 Bancorp Piper Jaffray 50 Weikang Bio Technology 50 KeyBanc Capital Markets 50 Piper Jaffray analyst 50 JPMorgan Basics 50 Kaufman Bros. LP 50 analyst Amit Hazan 50 Cochran Caronia Waller 50 ANALYST TAKE Stifel Nicolaus 50 Freidman Billings Ramsey 50 NYSE PJC 50 JMP Securities JMP 49 Inc. Nasdaq GLCH 49 Needham Growth Conference 49 Suntrust Robinson Humphrey 49 ThinkPanmure LLC 49 KeyBanc 49 Lauren Cooks Levitan 49 Joel Sendek 49 analyst Robert Cihra 49 Daniel Fannon 49 Stifel Nicholas 49 CK Cooper 49 FIG Partners 49 analyst Jesse Pichel 49 Liana Moussatos 49 FTN Midwest 49 analyst Richard Kugele 49 PiperJaffray 49 NYSE JEF 49 analyst Safa Rashtchy 49 Wedbush Morgan Securities 49 Fulcrum Global Partners 49 Semiannual Micro Cap 48 Ladenburg Thalman 48 Boenning & 48 HC Wainwright 48 Capstone Investments 48 Small Cap Institutional Investor 48 Broadpoint Gleacher Securities 48 Randal Konik 48 Khandaker Partners 48 BWS Financial 48 Petrie Parkman & 48 Broadpoint Securities 48 NASDAQ ARIA 48 Leerink 48 Wedbush Morgan California Dreamin 48 WR Hambrecht analyst 48 Keay Nakae 48 ICR XChange Conference 48 Annual Needham 48 Merrill Lynch OOTC MERIZ 48 Nicholas Aberle 48 Needham Growth 48 ThinkEquity Partners Growth 48 Inc. Nasdaq COWN 48 Jeffrey Frelick 48 Jonathan Ruykhaver 48 DA Davidson 48 Dr. Jim Birchenough 48 Analyst Cai von 48 Inc. NASDAQ BPSG 48 Soundview Technology 48 Credit Suisse 48 Friedman Billings 47 Sanford Bernstein 47 NYSE Amex LTS 47 Janney Montgomery 47 Oppenheimer 47 analyst Jonathan Schildkraut 47 Inc. AMEX LTS 47 JoAnne Feeney 47 Schwab Soundview 47 analyst Erik Suppiger 47 NYSE GHL 47 BIO InvestorForum 47 analyst Shebly Seyrafi 47 Broadpoint AmTech 47 ANALYST TAKE Bear Stearns 47 Joe Pantginis 47 RBC Capital Markets 47 JP Morgan 47 Cannacord Genuity 47 Acumen BioFin Rodman 47 Ardea Biosciences 47 Gabelli 47 Thomas Weisel Partners Tech# 47 D.A. Davidson 47 RBC Capital NYSE RY 47 analyst Jonathan Aschoff 47 Crowell Weedon & 47 Dahlman Rose & 47 Dahlman Rose 47 FBR Capital NASDAQ FBCM 47 TriPoint Global Research 47 Natixis Bleichroeder 47 Cowen NASDAQ COWN 47 Healthcare Tailwinds Conference 47 Kaufman Bros. Investor 47 Peter Goldmacher 47 analyst Ajit Pai 47 ThinkEquity Growth 47 RW Baird analyst 47 Sanford C. Bernstein 47 Inc. NASDAQ TWPG 47 ThinkGreen 47 Rajesh Ghai 47 Susquehanna Financial 47 Annual LD MICRO 47 Singular Research 47 Analyst Safa Rashtchy 47 Citi Investment 47 JB Hanauer & 47 Sterne Agee 47 Eric Martinuzzi 47 Hamed Khorsand 46 analyst Ananda Baruah 46 Canaccord Adams analyst 46 analyst Tore Svanberg 46 Sidoti Micro Cap 46 Lead Bookrunning Manager 46 Edwin Mok 46 analyst Mark Monane 46 Sandler O'Neill + 46 Needham Growth Stock 46 Nollenberger Capital Partners 46 CapStone 46 SG Cowen Securities 46 analyst Raj Denhoy 46 analyst Edwin Mok 46 JP Morgan SMid Cap 46 Threshold Pharmaceuticals Inc. 46 Equity Capital Markets 46 J.P. Morgan SMid Cap 46 Shemano Group 46 Doug Sipkin 46 analyst Peter Misek 46 JMP Securities Healthcare 46 AR Schmeidler & 46 Broadpoint Amtech 46 Daniel Berenbaum 46 Brigantine Advisors analyst 46 analyst Walter Piecyk 46 Broadpoint.Gleacher 46 RBC Capital 46 SoundView Technology 46 analyst Christa Quarles 46 analyst Randal Konik 46 COWN 46 Bear Stearns SMid Cap 46 analyst Tony Wible 46 Instream Partners 46 JM Dutton 46 Taglich Brothers 46 JB Hanauer 46 analyst Kristine Koerber 46 ThinkEquity downgraded 46 analyst Youssef Squali 46 Pali Capital 46 PRNewswire FirstCall Amylin Pharmaceuticals 46 www.piperjaffray.com 46 Emissary Capital 46 CLSA AsiaUSA Forum 46 Nasdaq ANDS announced 46 JMP Group 46 Betsy Van Hees 46 Eric Kainer 46 Artio Global Investors 46 Amy Noblin 46 AeA Classic Financial 46 Jefferies Broadview 46 ARYx Therapeutics Inc. 46 First PacTrust Bancorp 46 Richard Kugele 46 Inc JEF 46 Akhtar Samad 45 China Yida Holding 45 DA Davidson & 45 Johnson Steichen Kinnard 45 SoundView Technology Group 45 NASDAQ BMTI 45 Nasdaq MOGN 45 Two Upcoming Investor 45 EnerCom Oil 45 Tullis Dickerson 45 Ahmar Zaman 45 Oppenheimer OPY 45 RetailInvestorConferences.com 45 ThinkEquity analyst 45 Trius Therapeutics 45 RBC Capital Mkts Reiterate 45 Adam Klauber 45 Raj Denhoy 45 analyst William Tanona 45 Barton Crockett 45 Immunosyn Corporation 45 NASDAQ COWN 45 Walter Piecyk 45 BIOCOM Investor Conference 45 Group Inc JEF.N 45 Charles Strauzer 45 VIA Pharmaceuticals 45 Mark Bacurin 45 BIO Investor 45 Edward Tenthoff 45 Nasdaq MERR acted 45 FTN Equity 45 Questcor Pharmaceuticals Inc. 45 Inc. Nasdaq ICGE 45 Leerink Swann LLC 45 Sandler O'Neil 45 Maxcor Financial 45 Keybanc 45 LD MICRO Conference 45 Merrill Lynch Tradebot 45 LD Micro 45 Growth Institutional Investor 45 analyst Rommel Dionisio 45 Sanjay Shrestha 45 RedChip Visibility division 45 Hapoalim Securities 45 SoundView 45 Stifel Nicolaus Cleantech 45 AIVtech International 45 analyst Tim Klasell 45 Howe Barnes Hoefer 45 Capital Partners Energize 45 Safeguard Scientifics 45 Monness Crespi Hardt 45 Nasdaq AVNR 45 CE Unterberg Towbin Emerging 45 Delafield Hambrecht 45 Sara Michelmore 45 Goldman Sachs Communacopia 45 Piper Jaffray nyse PJC 45 Allos Therapeutics Incorporated 45 Inc. NYSE JEF 45 Nasdaq ADLR 45 BioCentury Future Leaders 45 Moelis & 45 Walter Nasdeo 45 Keybanc Capital Markets 45 consultancy Booz 45 sole bookrunning manager 45 Hulk Caris & 45 DXP Enterprises 45 Michael Cristinziano 45 Anadys Pharmaceuticals 45 Campos Lanuza 45 Anadys Pharmaceuticals Inc. 45 firm RHK 44 Merrill Lynch 44 Cantor Fitzgerald reiterates 44 Punk Ziegel & 44 Bonds.com 44 Jed Dorsheimer 44 CIBC World 44 Fifteenth Annual Emerging 44 Inc JEF JEF 44 Ault Glazer & 44 EdgeWater Research Partners 44 J.P. Morgan Healthcare 44 Sandler O'Neill Partners LP 44 Reiterates Hold 44 RF Lafferty 44 Al Kaschalk 44 Annabel Samimy 44 Altman Vilandrie & 44 Brean Murray downgrades 44 Arnie Berman 44 Tudor Pickering Holt 44 Gleacher 44 PiperJaffray analyst 44 SEB Enskilda 44 Jay Deahna 44 Goldman Sachs 44 analyst Gil Luria 44 Gleacher & 44 Co. NYSE WFC 44 Viriathus Capital 44 AMEX QSC 44 Justin Sebastiano 44 W. Seligman 44 Cannacord Adams 44 Joseph Pantginis 44 Oliver Schupp President 44 Creditsights 44 Phil Nalbone 44 Froley Revy Investment 44 GARP Research 44 Miller Buckfire 44 Gene Munster Piper Jaffray 44 Stelios Papadopoulos 44 Jason Kolbert 44 analyst Gurinder Kalra 44 Joel Fishbein 44 Brean Murray upgrades 44 Wachovia Securities 44 Annual Piper Jaffray 44 analyst Jim Reddoch 44 Jay Srivatsa 44 NASDAQ GEOI 44 GP Bullhound 44 Entropin 44 Annual BIO 44 Steve Massocca 44 analyst Dinesh Moorjani 44 Nasdaq QCOR 44 P. Klinefelter 44 TechAmerica AeA Classic 44 AMAG Pharmaceuticals Inc. 44 Anton Wahlman 44 Osterweis Capital Management 44 BioMimetic Therapeutics Inc. 44 Nasdaq GPRO announced 44 Nasdaq FMER 44 Stifel Financial 44 BMO Capital Markets 44 Rachael Rothman 44 Ananda Baruah 44 Presidio Pharmaceuticals 44 SSRX 44 RedChip Small Cap 44 fireside chat format 44 Todd Greenwald 44 Calyon Securities USA 44 Nasdaq EXAS today 44 Nasdaq THLD 44 Fox Pitt Kelton 44 AmTech Research 44 Xinyuan Real Estate 44 Inc. Nasdaq AMLN 44 Nasdaq INCY announced 44 Global Industrials 44 GCA Savvian Advisors 44 Annual Needham Growth 44 Annual OC 44 Approach Resources 44 Nasdaq DNDN 44 ANALYST TAKE Cowen 44 Inc. NASDAQ HITK 44 W. Ruttenbur 44 #-#-# richstern@sternco.com 44 JinkoSolar Holding Co. 44 analyst Arnab Chanda 44 ANALYST TAKE Goldman Sachs 44 Two Investor Conferences 44 EdgeWater Research 44 Altus Pharmaceuticals 44 Natixis Bleichroeder Hidden Gems 43 PDL BioPharma PDLI 43 Wachovia Capital Markets 43 Banc 43 ANALYST TAKE Lehman Brothers 43 Jerry Doctrow 43 NAREIT Investor Forum 43 Erik Suppiger 43 TripleTree 43 Avanir Pharmaceuticals 43 BancAnalysts Association 43 Sunesis Pharmaceuticals Inc. 43 Joe Osha 43 Inc BRNC 43 Nasdaq IDIX 43 WallStreet Research 43 RF Micro Device 43 NASDAQ ERES 43 ThinkEquity Partners 5th 43 Knight Libertas LLC 43 Needham 43 NASDAQ AFFY 43 Oppenheimer Industrials 43 Soleil Securities 43 Thoratec Presentation 43 Eric Ende 43 Biomarin Pharm 43 TW Telecom 43 Stifel 43 Cepheid NASDAQ CPHD 43 Bert Hazlett 43 Wolfe Trahan 43 Semico Research Corp. 43 Annual Institutional Investor 43 TD Newcrest 43 BMO Capital 43 Entropic Comms 43 Rubicon Technology 43 ANALYST TAKE JPMorgan 43 Inc NWY 43 analyst Ivan Feinseth 43 Outperform rating 43 Farlie Turner 43 F5 Networks NASDAQ FFIV 43 Aurelius Consulting Group 43 PrinceRidge 43 Quynh Pham 43 Inc. NASDAQ RODM 43 Andrew Barwicki 43 analyst Satya Chillara 43 analyst Joanne Wuensch 43 Houlihan Lokey Howard 43 NYSE LAZ 43 NASDAQ ONXX 43 Harris Nesbitt 43 Qatalyst Group 43 James NYSE RJF 43 Rajeev Chand 43 NASDAQ APPY 43 Morgan Stanley 43 Alan Bezoza 43 SYS CON AJAXWorld RIA 43 Kenneth Muth 43 analyst Katherine Egbert 43 Celgene NASDAQ CELG 43 Jesse Pichel 43 Inc. NASDAQ AREX 43 Fixed Income Capital Markets 43 Russell Skibsted 43 analyst Moshe Katri 43 Inc. Nasdaq ANDS 43 Ninth Annual JMP 43 BTIG 43 NASDAQ IPXL 43 NASDAQ SLXP 43 JPMorgan SMid Cap 43 Craig Hallum Institutional Investor 43 Brent Thill 43 Pacific Crest 43 analyst Kemp Dolliver 43 Skystar Bio Pharmaceutical 43 Sector Performer 43 Wedbush analyst 43 Rodman Renshaw 43 Brian Gesuale 43 Fulcrum Global 43 Investology 43 NovaBay Pharmaceuticals 43 Aethlon Medical OTCBB AEMD 43 analyst Shaul Eyal 43 Genitope Corporation 43 Ben Mogil 43 Nils Larsen Tribune 43 Schwab SoundView 43 analyst Bruce Cranna 43 Gary Hsueh 43 Datacomm Research 43 MCF Asset Management 43 & Renshaw Techvest 43 BGB Securities 43 NASDAQ IRWD 43 Interpret LLC 43 Needham Biotechnology 43 Dynavax Technologies 43 Joe Laezza Glowpoint 43 Bank Sarasin 43 IPAA OGIS San Francisco 43 Vik Grover 43 NYSE IVZ 43 ENSCO PLC 43 WestPark Capital 43 CSFB 43 Inc. NASDAQ ITMN 43 Miller Tabek 43 Goldman Sachs Communacopia XIX 43 ThinkEquity upgraded 43 DnB NOR Markets 43 Cormark Securities 43 CombinatoRx Incorporated NASDAQ CRXX 43 analyst Tristan Gerra 42 analyst Mitch Kummetz 42 Zelos Group 42 Ironwood Pharmaceuticals Inc. 42 Durect Corporation 42 Natexis Bleichroeder 42 Institutional Investor Forum 42 Ardea Biosciences Inc. 42 BPSG 42 Brad Reback 42 Piacente Group 42 Nasdaq IPXL 42 Joanne Wuensch 42 Daniel Renouard 42 Nasdaq ANDS 42 Stifel Nicolaus Weisel 42 FLML 42 bookrunning manager 42 Nasdaq ISTA 42 CorpHQ 42 Annual JMP Securities 42 Steven Alexopoulos 42 SciClone Pharmaceuticals 42 analyst Jeffrey Fidacaro 42 Synergetics USA 42 Inhibitex INHX 42 Investor Conferences 42 Sunesis Pharmaceuticals 42 Medicis NYSE MRX 42 SunTrust Robinson 42 Katherine Egbert 42 analyst Sasa Zorovic 42 Micro Cap Conference 42 BRE Properties BRE 42 Synergy Pharmaceuticals 42 OptionsXpress Holdings 42 Eli Lilly NYSE LLY 42 Lazard LAZ 42 Inc. NASDAQ MRNA 42 Jonathan Aschoff 42 JPMorgan 42 Tapestry Pharmaceuticals Inc. 42 Ken Cacciatore 42 Idenix Pharmaceuticals Inc. 42 Crowell Weedon 42 Reiterates Neutral Rating 42 Goldman Sachs Communacopia XVII 42 Bryan Garnier 42 Therapeutic Competitors 42 Small Cap Ideas 42 Threshold Pharmaceuticals THLD 42 David Amsellem 42 Inc. NASDAQ VVUS 42 Nasdaq ITMN 42 Petrie Parkman 42 ImmunoGen Inc. 42 Semtech SMTC 42 analyst Emme Kozloff 42 Probitas Partners 42 JMP Securities downgraded 42 Evercore Partners EVR 42 underwriter WR Hambrecht 42 Nasdaq CADX 42 NASDAQ GPRO 42 DealFlow Media 42 Piper Jaffray downgraded 42 Nasdaq ENZN 42 Sinopac Securities 42 Questcor Pharmaceuticals 42 Webcast Presentations 42 Velocity Interactive 42 Sawaya Segalas & 42 Aderis 42 NASDAQ VRTX 42 Benny Lorenzo 42 ROTH #nd 42 Moshe Katri 42 Fiduciary Asset Management 42 Limited NASDAQ HSFT 42 Xenoport Inc. 42 Ursaner 42 Oscar Gruss 42 Garo Toomajanian 42 Ladenburg Thalmann analyst 42 Rutberg 42 SMH Capital 42 BMRN 42 NorthPoint Trading Partners 42 Avondale Partners 42 BioMarin Pharmaceutical 42 Corporation NASDAQ LRCX 42 Spreadtrum Comms 42 analyst Arvind Bhatia 42 Synta Pharmaceuticals 42 NASDAQ ALTU 42 UBS Investment 42 Arnie Ursaner 42 Tellabs Presentation 42 Underperform Rating 42 ThinkEquity initiated 42 Hana Biosciences 42 Volterra Semiconductor 42 Brian Bapty 42 Panmure Gordon 42 RW Roge & 42 Bjurman Barry 42 Canaccord Genuity Cardiovascular 42 Makovsky + 42 Matt Nemer 42 Novelos Therapeutics Inc. 42 analyst Sterling Auty 42 RICHFIELD Minn. Best Buy 42 David Turkaly 42 ICAP Equities 42 Broadpoint.AmTech analyst 42 LLC Brenda Grandell 42 Emerging Growth 42 Rob Cihra 42 Sector Underperformer 42 Simeonidis 42 Reynders Gray 42 Wedbush Morgan reiterate 42 Todd Raker 42 CAMBRIDGE Mass. Vertex Pharmaceuticals 42 Mark Schoenebaum 42 Krishna Shankar 42 Reiterates Buy 42 Altus Pharmaceuticals Inc. 42 Novellus Systems Inc 42 NYSE CYS 42 Nasdaq SOMX 42 Inc. Nasdaq IMGN 42 Scott Mushkin 42 FAF Advisors 42 Weisel Partners 42 Underperform 42 Merck Finck 42 PMC Sierra NASDAQ PMCS 42 Inc. Nasdaq ARQL 42 Nasdaq BMRN 42 Piper Jaffray downgrades 42 Jeremy Sussman 42 Cantor Fitzgerald 42 OC Growth 42 Bayhill Therapeutics 42 Luminent Mortgage Capital 42 Piper Jaffray reiterates 42 Endo Pharmaceuticals NASDAQ ENDP 42 analyst Jason Helfstein 42 Alesco Financial 42 Upcoming Investor Events 41 Natixis Bleichroeder Second 41 NYSE EVR 41 Gilead Sciences Inc 41 analyst Patrick Walravens 41 R. Shawley 41 Jefferies JEF 41 Upcoming Investor Conference 41 Inc. NASDAQ ACUS 41 ROTH #rd 41 Lehman Brothers T4 41 analyst Mehdi Hosseini 41 Inc. NASDAQ COWN 41 http:/www.piperjaffray.com 41 OneMedForum San Francisco 41 Global Leveraged Finance 41 Patrick Walravens 41 NuVasive NASDAQ NUVA 41 Matthew Kather 41 Moussatos 41 Optimer Pharmaceuticals Inc. 41 PrivateRaise 41 RedChip Investor 41 NASDAQ AUXL 41 Juniper Networks NASDAQ JNPR 41 Attention Syndicate Prospectus 41 Houlihan Lokey 41 Annual Canaccord Adams 41 Piper Jaffray Upgrades 41 EarlyBirdCapital Inc. 41 Qlik Technologies Inc 41 Seventh Annual JMP 41 Renshaw Annual Global 41 Urigen Pharmaceuticals Inc. 41 RedChip Independent 41 analyst Andrey Glukhov 41 Inc. NASDAQ AVNR 41 Kian Abouhossein 41 Michael Masdea 41 TSRX 41 Valeant Pharmaceuticals NYSE VRX 41 Carl Hymans GS 41 NYSE VQ 41 Deane Dray 41 sole bookrunning 41 MBRX 41 J. DeLuccia 41 NASDAQ UACL 41 BernsteinResearch 41 Scot Ciccarelli 41 Keybanc NYSE 41 analyst Mark Schoenebaum 41 Eighth Annual JMP 41 Wintrust Financial Corporation 41 Aimee Marcel Remey 41 Wells Fargo Initiates Coverage 41 Pancari 41 NASDAQ ZIOP 41 Reiterates Buy rating 41 Maintains Hold 41 Tejas Securities 41 Celldex Therapeutics Inc. 41 Louis Miscioscia 41 Jpmorgan Chase 41 JMP Securities analyst 41 Institutional Investors Conference 41 ImmunoCellular Therapeutics 41 Morgan Stanley NYSE BDJ 41 Capital Markets Origination 41 Broadpoint 41 PrivateBancorp 41 BRE Properties 41 Midwest IDEAS Investor 41 MASS Opportunities 41 Jonathan Dorsheimer 41 Market Perform 41 Stephen Gengaro 41 CardioVascular BioTherapeutics Inc. 41 ZIOPHARM Oncology Inc. 41 Ittai Kidron 41 BNY Capital Markets 41 Stern Agee 41 TWO.WS 41 Mr. Bentsur 41 AVANIR Pharmaceuticals 41 Peer Perform rating 41 W Baird 41 Avik Roy 41 AVNW 41 Syndicate Prospectus Department 41 analyst Eric Beder 41 Edwin Groshans 41 PRNewswire FirstCall InterMune 41 Vijay Rakesh 41 Tenthoff 41 Northcoast Research 41 NWY 41 SMid Cap Investor 41 RedChip Announces 41 Investment Counsel 41 Miller Tabak 41 T3i Group 41 Finisar NASDAQ FNSR 41 Nasdaq INCY 41 analyst Uche Orji 41 ZIOPHARM Oncology 41 Two Upcoming Conferences 41 Nasdaq MAPP 41 Wilshire Bancorp Inc. 41 Grasher 41 Ventrus Biosciences 41 Calix Networks 41 Friedman Billings reiterate 41 Echo Therapeutics 41 RBC Capital Mkts 41 Canaccord 41 Nasdaq RDEA 41 Mkt Perform 41 NAREIT REITWeek 41 Cai von Rumohr 41 Berkery Noyes 41 Resumes Coverage 41 China Sunergy 41 Joel Plasco 41 NASDAQ QCOR 41 Global MegaTrends Fund 41 Umpqua Holdings 41 OLGX 41 PIPEs Conference 41 Mayank Tandon 41 Neely JN Tamminga 41 Alexia Quadrani 41 Cogent Consulting 41 Corporation NASDAQ PRXL 41 Neostem 41 newratings.com Analyst Jonathan Aschoff 41 Invesco NYSE IVZ 41 Cree NASDAQ CREE 41 ConvergEx Group 41 NASDAQ SAPE 41 Barry Tarasoff 41 Molowa 41 NASDAQ TICC announced 41 Stacey Widlitz analyst 41 Overweight rating 41 Brian Pitz 41 Pluristem Therapeutics Inc. 41 FBR Capital Upgrades 41 ICR Xchange 41 Charles Messman 41 Herbert McDade 41 Nasdaq OSCI 41 PRNewswire FirstCall DURECT Corporation 41 Squali 41 James McIlree 41 analyst Lawrence Klatzkin 41 Renaissance Capital 41 PRNewswire FirstCall Sunesis Pharmaceuticals 41 NASDAQ ISTA 41 Ltd. SHOO 41 Renshaw 9th 41 NASDAQ CYTX 41 Jeff Fidacaro 41 Hussman Econometrics Advisors 41 John DiFucci 41 PRNewswire FirstCall Onyx Pharmaceuticals 41 Rexahn Pharmaceuticals Inc. 41 Marvell Technology NASDAQ MRVL 41 Institutional Investor Conference 41 Nathan Schneiderman 41 Punk Ziegel analyst 41 Lazard Capital reiterate 41 ViroPharma Incorporated NASDAQ VPHM 41 Dana Telsey 41 Jamie Dimon JPMorgan Chase 41 Doug Creutz 41 Renshaw Techvest 7th 41 analyst Robert Drbul 41 Healthcare Tailwinds 41 Mark Astrachan 41 Jami Rubin 41 Inc. NASDAQ ACOR 41 Ariad Pharmaceuticals 41 Ajit Pai 41 Sagent Advisors 41 Lee Fensterstock 41 Reiterates Hold Rating 41 Tal Liani 41 analyst Louis Miscioscia 41 KBRO 41 Monane 41 Emkay Global Financial 41 Upcoming Investor 41 Isaac Ro 41 visit www.taglich.com 41 stockbroker Killik & 41 Depomed NASDAQ DEPO 41 reaffirmed Outperform rating 41 BTIG LLC 41 Sector Outperform 41 analyst Adrienne Tennant 41 analyst Alex Gauna 41 Piper Jaffray Cos 41 Howard Weil 41 DoubleLine Capital 41 ABN AMRO Incorporated 41 Credit Suisse First 41 Maintains Buy 41 A. Sasa Zorovic 41 WestPark Capital Inc. 41 Meredith Whitney Advisory 41 Chordiant Software CHRD 41 Reiterate Buy rating 41 Apricus Biosciences 41 Akesis Pharmaceuticals 41 George Staphos 41 Benjamin Schachter 41 NASDAQ BMRN 41 Jason Avilio 41 Inc. Nasdaq EXEL 40 Stifel Nicolaus downgraded 40 Tri Artisan 40 ThinkEquity Partners analyst 40 Jomar Lacson 40 Matthew DiFrisco 40 CONTACT ICR 40 PRNewswire FirstCall Emisphere Technologies 40 Bonds.com Group 40 RedChip 40 analyst Benjamin Mogil 40 Canaccord Adams Global 40 MS NYSE MWJ 40 NASDAQ FBCM 40 Navdeep Jaikaria 40 analyst Randall Stanicky 40 PRNewswire FirstCall Indevus Pharmaceuticals 40 analyst Guy Moszkowski 40 Mkt Outperform 40 FBR Capital Maintains 40 SMH Capital Markets 40 Jim Feldhan 40 NASDAQ ALXN 40 analyst Anthony Chukumba 40 THE SPARK Analyst 40 CeNeRx BioPharma 40 JA Solar 40 PCRX 40 Siebert Brandford Shank 40 Nasdaq AUXL 40 Analyst Tristan Gerra 40 Canaccord Adams Musculoskeletal 40 Josephthal 40 NYSE GBE 40 Heather Bellini 40 Inc. Nasdaq PTIE 40 Tudor Pickering 40 Terker And 40 JMP Securities reiterate 40 Kellner DiLeo Cohen 40 Upcoming Investor Conferences 40 RDEA 40 CoBiz Financial 40 Seattle Genetics SGEN 40 Mark Edelstone 40 Broadcom NASDAQ BRCM 40 Jennifer Fritzsche 40 Inc. Nasdaq AVRX 40 #th Annual J.P. 40 Drew Brosseau 40 Evercore Partners 40 analyst Bruce Harting 40 Nasdaq AEZS 40 Inc. NYSE NWY 40 analyst Yaron Werber 40 Jennifer Childe 40 Westrock Advisors 40 analyst Jeffrey Klinefelter 40 Idenix Pharma 40 Wedbush Morgan analyst 40 Acorda Therapeutics NASDAQ ACOR 40 Maintains Outperform 40 broker Killik 40 Dhulsini de Zoysa 40 Dahlman Rose downgraded 40 Joe Giamichael 40 WR Hambrecht reiterate

Back to home page